Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

View graph of relations

Related Research Unit(s)

Detail(s)

Original languageEnglish
Pages (from-to)695-697
Journal / PublicationEuropean Intellectual Property Review
Volume42
Issue number11
Publication statusPublished - 20 Nov 2020

Abstract

As the world continues to battle the Covid-19 pandemic, innovation and technology have found a new battleground. Against the backdrop of the emerging patent controversies surrounding Covid-19 vaccines and therapeutics, this opinion reconsiders the theoretical justification for the grant of pharmaceutical patents.

Research Area(s)

  • Coronavirus, Morals and law, Patentable inventions, Patents, Pharmaceuticals

Bibliographic Note

Month information for this publication is provided by the author(s) concerned.